首页 | 本学科首页   官方微博 | 高级检索  
检索        

雷贝拉唑联合莫沙必利治疗反流性食管炎的临床观察
引用本文:陈秀伟.雷贝拉唑联合莫沙必利治疗反流性食管炎的临床观察[J].中国医药指南,2011,9(2):20-21.
作者姓名:陈秀伟
作者单位:湖南省湘乡市中医院消化内科,湖南,湘乡,411220
摘    要:目的探讨雷贝拉唑联合莫沙必利治疗反流性食管炎(RE)的近期疗效和安全性。方法将经胃镜证实的反流性食管炎患者110例随机分成治疗组和对照组各55例。治疗组:口服雷贝拉唑10mg,早晚各1次餐前服用,莫沙必利每次5mg,3次/d,餐前半小时服用;对照组:奥美拉唑20mg/d,餐前服用,莫沙必利服用方法同上。两组患者均完成6周治疗,对其临床疗效和安全性进行临床观察。结果两组临床症状缓解总有效率(临床症状改善和胃镜下病变黏膜缓解情况)分别为治疗组94.54%(52/55),对照组76.36%(42/55),治疗组总有效率优于对照组(P<0.05),且不良反应少。结论雷贝拉唑联合莫沙必利治疗反流性食管炎临床症状改善迅速,临床疗效优于奥美拉唑联合莫沙必利治疗反流性食管炎,且安全可靠。

关 键 词:雷贝拉唑  莫沙必利  反流性食管炎

Clinical Observation of Rabeprazole Joint Mosapride will the Treatment of the Reflux esophagitis
CHEN Xiu-wei.Clinical Observation of Rabeprazole Joint Mosapride will the Treatment of the Reflux esophagitis[J].Guide of China Medicine,2011,9(2):20-21.
Authors:CHEN Xiu-wei
Institution:CHEN Xiu-wei (Department of Gastroenterology,Xiangxiang TCM Hospital of Hunan,Xiangxiang 411220,China)
Abstract:Objective Efficacy and safety of Rabeprazole joint Mosapride treatment of the reflux esophagitis(RE).Methods By gastroscope confirmed the reflux esophagitis 110 cases were randomly divided into patients 55 treatment group and control group.Treatment group: oral Rabeprazole 10mg evening meal times,Mosapride will take time,three times a day,5mg,half an hour before meal.Control group: Prilosec 20mg/d,before dinner,Mosapride will take a method.Two groups of patients were treated for six weeks to finish,the clin...
Keywords:Rabeprazole  Mosapride  Reflux esophagitis  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号